Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Prostate Cancer
100%
Neoplasm
56%
Clear Cell Renal Cell Carcinoma
49%
Gleason Score
40%
Pathologist
38%
Biopsy Technique
35%
Prostatectomy
32%
Tumor
30%
Intraductal Carcinoma
27%
Morphology
26%
Diseases
25%
Needle Biopsy
23%
Transitional Cell Carcinoma
23%
Carcinoma
19%
Prostate Biopsy
19%
High-Grade Prostatic Intraepithelial Neoplasia
19%
Malignant Neoplasm
18%
Reproducibility
18%
Magnetic Resonance Imaging
18%
Prostate Carcinoma
17%
Prostate Specific Antigen
16%
Histology
15%
Prostate Adenocarcinoma
14%
Clear Cell
13%
Metastatic Carcinoma
13%
Genetics
13%
Basal Cell
12%
Immunohistochemistry
12%
Kidney Tumour
11%
Gene Fusion
11%
Adenocarcinoma
10%
Papillary Renal Cell Carcinomas
10%
Androgen
10%
Cancer Growth
9%
Bladder Cancer
9%
Biological Marker
9%
Differential Diagnosis
8%
Surgical Margin
8%
Carbon 11
7%
Choline
7%
Stroma
7%
Radiation Therapy
7%
Fluorescence in Situ Hybridization
6%
Cancer Diagnosis
6%
Radical Nephrectomy
6%
Surgeon
6%
Cancer
6%
Prostatic Intraepithelial Neoplasia
5%
Racemase
5%
Recurrent Disease
5%
Keyphrases
Prostate Cancer
83%
Tumor
33%
Renal Cell Carcinoma
33%
Pathologists
29%
Prostate Carcinoma
19%
Prostate
19%
Urothelial Carcinoma
18%
Gene Fusion
18%
Transmembrane Protease Serine 2 (TMPRSS2)
17%
Prostate Biopsy
16%
Prostate Cancer Progression
14%
Intraductal Carcinoma
14%
Radical Prostatectomy
14%
Intraductal Carcinoma of the Prostate (IDC-P)
14%
Carcinoma
13%
High Grade Prostatic Intraepithelial Neoplasia (HGPIN)
13%
Interobserver Reproducibility
12%
TMPRSS2-ERG Fusion
12%
Overexpression
11%
Urologic
11%
Basal Cell
10%
Core Needle Biopsy
10%
Cribriform
10%
Clear Cell Renal Cell Carcinoma (ccRCC)
10%
Prostate Gland
10%
Genitourinary Pathology
10%
Fluorescence in Situ Hybridization
10%
Metastasis
9%
Metastatic Prostate Cancer
9%
Prostate-specific Antigen
9%
ETV1
8%
Renal Tumor
8%
Prostatectomy Specimen
8%
AMACR
8%
Benign Prostate Disorders
8%
ETV4
8%
Gleason Grading
7%
Immunohistochemistry
7%
Grade Group
7%
Surgical Margin
7%
Glands
7%
CK 7
7%
Papillary Renal Cell Carcinoma (pRCC)
7%
Gleason Pattern 4
7%
Prostatic Adenocarcinoma
7%
Gene Aberrations
7%
Gleason Score
7%
Papillary
6%
Genetic Modification
6%
International Society of Urological Pathology
6%